Longitudinal analysis of invariant natural killer T cell activation reveals a cMAF-associated transcriptional state of NKT10 cells
- PMID: 36458691
- PMCID: PMC9831610
- DOI: 10.7554/eLife.76586
Longitudinal analysis of invariant natural killer T cell activation reveals a cMAF-associated transcriptional state of NKT10 cells
Abstract
Innate T cells, including CD1d-restricted invariant natural killer T (iNKT) cells, are characterized by their rapid activation in response to non-peptide antigens, such as lipids. While the transcriptional profiles of naive, effector, and memory adaptive T cells have been well studied, less is known about the transcriptional regulation of different iNKT cell activation states. Here, using single-cell RNA-sequencing, we performed longitudinal profiling of activated murine iNKT cells, generating a transcriptomic atlas of iNKT cell activation states. We found that transcriptional signatures of activation are highly conserved among heterogeneous iNKT cell populations, including NKT1, NKT2, and NKT17 subsets, and human iNKT cells. Strikingly, we found that regulatory iNKT cells, such as adipose iNKT cells, undergo blunted activation and display constitutive enrichment of memory-like cMAF+ and KLRG1+ populations. Moreover, we identify a conserved cMAF-associated transcriptional network among NKT10 cells, providing novel insights into the biology of regulatory and antigen-experienced iNKT cells.
Keywords: activation; adipose tissue; cellular metabolism; computational biology; human; iNKT cells; immunology; inflammation; mouse; scRNA-Seq; systems biology; transcriptional remodeling.
© 2022, Kane et al.
Conflict of interest statement
HK, NL, ÁN, AG, HK, AA, BK, BS, MB, LL No competing interests declared
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig1.gif)
![Figure 1—figure supplement 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig1-figsupp1.gif)
![Figure 1—figure supplement 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig1-figsupp2.gif)
![Figure 1—figure supplement 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig1-figsupp3.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig2.gif)
![Figure 2—figure supplement 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig2-figsupp1.gif)
![Figure 2—figure supplement 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig2-figsupp2.gif)
![Figure 2—figure supplement 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig2-figsupp3.gif)
![Figure 2—figure supplement 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig2-figsupp4.gif)
![Figure 2—figure supplement 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig2-figsupp5.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig3.gif)
![Figure 3—figure supplement 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig3-figsupp1.gif)
![Figure 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig4.gif)
![Figure 4—figure supplement 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig4-figsupp1.gif)
![Figure 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig5.gif)
![Figure 5—figure supplement 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig5-figsupp1.gif)
![Figure 5—figure supplement 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig5-figsupp2.gif)
![Figure 5—figure supplement 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig5-figsupp3.gif)
![Figure 5—figure supplement 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig5-figsupp4.gif)
![Figure 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig6.gif)
![Figure 6—figure supplement 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig6-figsupp1.gif)
![Figure 6—figure supplement 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig6-figsupp2.gif)
![Figure 6—figure supplement 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig6-figsupp3.gif)
![Figure 6—figure supplement 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig6-figsupp4.gif)
![Figure 6—figure supplement 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig6-figsupp5.gif)
![Figure 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig7.gif)
![Figure 7—figure supplement 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9831610/bin/elife-76586-fig7-figsupp1.gif)
Similar articles
-
Recent advances regarding the potential roles of invariant natural killer T cells in cardiovascular diseases with immunological and inflammatory backgrounds.Int Immunol. 2024 Jul 13;36(8):377-392. doi: 10.1093/intimm/dxae019. Int Immunol. 2024. PMID: 38557824 Review.
-
Zeb2 regulates differentiation of long-lived effector of invariant natural killer T cells.Commun Biol. 2023 Oct 30;6(1):1070. doi: 10.1038/s42003-023-05421-w. Commun Biol. 2023. PMID: 37903859 Free PMC article.
-
Harnessing invariant natural killer T cells to control pathological inflammation.Front Immunol. 2022 Sep 15;13:998378. doi: 10.3389/fimmu.2022.998378. eCollection 2022. Front Immunol. 2022. PMID: 36189224 Free PMC article. Review.
-
Transcriptome and chromatin landscape of iNKT cells are shaped by subset differentiation and antigen exposure.Nat Commun. 2021 Mar 4;12(1):1446. doi: 10.1038/s41467-021-21574-w. Nat Commun. 2021. PMID: 33664261 Free PMC article.
-
Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation.Viruses. 2012 Oct 23;4(10):2379-99. doi: 10.3390/v4102379. Viruses. 2012. PMID: 23202469 Free PMC article. Review.
Cited by
-
Role of CD1d and iNKT cells in regulating intestinal inflammation.Front Immunol. 2024 Jan 11;14:1343718. doi: 10.3389/fimmu.2023.1343718. eCollection 2023. Front Immunol. 2024. PMID: 38274786 Free PMC article. Review.
-
Unique adipose tissue invariant natural killer T cell subpopulations control adipocyte turnover in mice.Nat Commun. 2023 Dec 21;14(1):8512. doi: 10.1038/s41467-023-44181-3. Nat Commun. 2023. PMID: 38129377 Free PMC article.
-
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy.J Hematol Oncol. 2023 Oct 25;16(1):108. doi: 10.1186/s13045-023-01504-7. J Hematol Oncol. 2023. PMID: 37880715 Free PMC article. Review.
References
-
- Alfen JS, Larghi P, Facciotti F, Gagliani N, Bosotti R, Paroni M, Maglie S, Gruarin P, Vasco CM, Ranzani V, Frusteri C, Iseppon A, Moro M, Crosti MC, Gatti S, Pagani M, Caprioli F, Abrignani S, Flavell RA, Geginat J. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease. The Journal of Allergy and Clinical Immunology. 2018;142:1537–1547. doi: 10.1016/j.jaci.2017.12.984. - DOI - PubMed
-
- Angiari S, Runtsch MC, Sutton CE, Palsson-McDermott EM, Kelly B, Rana N, Kane H, Papadopoulou G, Pearce EL, Mills KHG, O’Neill LAJ. Pharmacological activation of pyruvate kinase M2 inhibits CD4+ T cell pathogenicity and suppresses autoimmunity. Cell Metabolism. 2020;31:391–405. doi: 10.1016/j.cmet.2019.10.015. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources